A comprehensive meta-analysis of stem cell therapy for liver failure: Assessing treatment efficacy and modality
This comprehensive analysis underscores the potential of MSC therapy in significantly improving survival and clinical outcomes in patients with liver failure, highlighting the superior benefits of allogeneic MSCs and deep vessel plus single injection administration.
Authors
- Dongqing Zhang
- Jin‐Shui Pan (ORCID: https://orcid.org/0000-0002-9586-7760)
- Yueyong Zhu (ORCID: https://orcid.org/0000-0002-0746-4911)
- Haibing Gao (ORCID: https://orcid.org/0000-0002-7266-1487)
- Shenglong Lin
- Ziyuan Liao
- Huaxi Ma
Institutions
- Fujian Medical University (CN)
- Mengchao Hepatobiliary Hospital (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- Annals of Hepatology
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1016/j.aohep.2024.101586
- Citations
- 4
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- Fujian Medical University